- About
- Advertise
- Author Guidelines
- Contact MJH
- Editorial Advisory Board
- Ethics Policy
- Do Not Sell My Personal Information
- LCGC Staff
- Privacy Policy
- Permissions
- Subscriptions
- Terms and Conditions
© 2023 MJH Life Sciences™ and Chromatography Online. All rights reserved.
Special Issues-10-02-2015 | LCGC Supplements
Special Issues
Advances in Biopharmaceutical Analysis
October 02, 2015
Introduction
33
10
Advances in Biopharmaceutical Analysis
Modern Column Technologies for the Analytical Characterization of Biopharmaceuticals in Various Liquid Chromatographic Modes
October 02, 2015
Features
33
10
Modern Column Technologies for the Analytical Characterization of Biopharmaceuticals in Various Liquid Chromatographic Modes
Advances in Liquid Chromatography–Tandem Mass Spectrometry (LC–MS–MS)-Based Quantitation of Biopharmaceuticals in Biological Samples
October 02, 2015
Features
33
10
Advances in Liquid Chromatography–Tandem Mass Spectrometry (LC–MS–MS)-Based Quantitation of Biopharmaceuticals in Biological Samples
Analyzing Host Cell Proteins Using Off-Line Two-Dimensional Liquid Chromatography–Mass Spectrometry
October 02, 2015
Features
33
10
Analyzing Host Cell Proteins Using Off-Line Two-Dimensional Liquid Chromatography–Mass Spectrometry
Higher Order Mass Spectrometry Techniques Applied to Biopharmaceuticals
October 02, 2015
Features
33
10
Higher Order Mass Spectrometry Techniques Applied to Biopharmaceuticals
Monoclonal Antibodies and Biosimilars — A Selection of Analytical Tools for Characterization and Comparability Assessment
October 02, 2015
Features
33
10
With the top-selling mAbs evolving out of patent there has been a growing interest in the development of biosimilars. In demonstrating comparability to the originator product, biosimilar developers are confronted with an enormous analytical challenge. This article presents a selection of state-of-the-art analytical tools for mAb characterisation and comparability assessment.
Harnessing the Benefits of Mass Spectrometry for In-depth Antibody Drug Conjugates Analytical Characterization
October 02, 2015
Features
33
10
Recent progress in high-resolution mass spectrometry (HRMS) and liquid chromatography–mass spectrometry (LC–MS) methods for the structural characterization of brentuximab vedotin and trastuzumab emtansine are presented.
Vol 28 No s10 LCGC Europe October 2015 Advances in Biopharmaceutical Analysis Supplement PDF
October 02, 2015
Issue PDF
33
10
Click the title above to open the LCGC Europe October 2015 Advances in Biopharmaceutical Analysis Supplement, Vol 28, No s10, in an interactive PDF format.